Early outcome of a 31‐gene expression profile test in 86 AJCC stage IB‐II melanoma patients. A prospective multicentre cohort study

BACKGROUND: The clinical and pathological features of primary melanoma are not sufficiently sensitive to accurately predict which patients are at a greater risk of relapse. Recently, a 31‐gene expression profile (DecisionDx‐Melanoma) test has shown promising results. OBJECTIVES: To evaluate the earl...

Descripción completa

Detalles Bibliográficos
Autores principales: Podlipnik, S., Carrera, C., Boada, A., Richarz, N.A., López‐Estebaranz, J.L., Pinedo‐Moraleda, F., Elosua‐González, M., Martín‐González, M.M., Carrillo‐Gijón, R., Redondo, P., Moreno, E., Malvehy, J., Puig, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles and Short Reports Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483866/
https://www.ncbi.nlm.nih.gov/pubmed/30702163
http://dx.doi.org/10.1111/jdv.15454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483866/
https://www.ncbi.nlm.nih.gov/pubmed/30702163
http://dx.doi.org/10.1111/jdv.15454

Ejemplares similares